Home > Drug Search >
  • company_query: Allertein
  •   > 
Drug Filter
Category:
chemistry (4) biology (46)
Status:
Approved (3) Phase Ⅲ (7) Phase Ⅱ (13) Phase Ⅰ (26)
Clinical Stage:
Pending (17) Active (23) Discontinued (6)
Bio-Type:
Gene therapy (3) Fcab fragment (1) Cell therapy (1) Vaccine (34) Allergen extract (2) Recombinant enzyme (1) Recombinant cytokines (1) Whole antibody (1) Fab fragment (1)
Indication:
Allergic rhinitis (AR) (1) Allergic rhinoconjunctivitis (2) Breast cancer (3) Avian influenza (3) Herpes simplex virus (1) Diarrhea (1) Anal cancer (1) Vulvovaginal cancer (1) Gastric cancer (1) Wet age-related macular degeneration (1) HCV infection (1) HIV infection (8) Timothy grass pollen-induced allergic rhinitis (1) Influenza virus infection (4) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (3) Viral infections (1) Peyronie's disease (1) Dermal scarring (1) Solid tumours (2) Peanut hypersensitivity (1) Tuberculosis (1) Visceral leishmaniasis (1) Nonaka distal myopathy (1) Coronavirus infection (1) Genital warts (1) Influenza A virus infections (1) Radiodermatitis (1) Anthrax (2) Cervical carcinoma (1) Malaria (2) Allergic asthma (1) Respiratory syncytial virus infection (1) Mesothelioma (1) Ebola virus disease (EVD) (4) Human papillomavirus infections (HPV) (1) Hypersensitivity (4)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top